Literature DB >> 1330682

Neuronal-type nicotinic receptors in human neuroblastoma and small-cell lung carcinoma cell lines.

P Tarroni1, F Rubboli, B Chini, R Zwart, M Oortgiesen, E Sher, F Clementi.   

Abstract

A beta subunit of the neuronal nicotinic receptor, sharing 88% homology with the rat beta 4 subunit, has been cloned from a human neuroblastoma cell line. The gene encoding the human beta 4 subunit is expressed in association with the alpha 3 gene in neuroblastoma and small-cell lung carcinoma cell lines. Patch-clamp experiments and radioligand binding assays confirm that these neuroendocrine tumor cell lines express functional neuronal nicotinic receptors. We suggest that these receptors might play a crucial role in the control of neurotransmitter and hormone secretion from neurosecretory human tumors.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1330682     DOI: 10.1016/0014-5793(92)81411-e

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  12 in total

1.  Small-cell lung cancer (human): potentiation of endocytic membrane activity by voltage-gated Na(+) channel expression in vitro.

Authors:  P U Onganer; M B A Djamgoz
Journal:  J Membr Biol       Date:  2005-03       Impact factor: 1.843

2.  The nicotinic receptor antagonists abolish pathobiologic effects of tobacco-derived nitrosamines on BEP2D cells.

Authors:  Juan Arredondo; Alex I Chernyavsky; Sergei A Grando
Journal:  J Cancer Res Clin Oncol       Date:  2006-07-12       Impact factor: 4.553

3.  Comparative structure of human neuronal alpha 2-alpha 7 and beta 2-beta 4 nicotinic acetylcholine receptor subunits and functional expression of the alpha 2, alpha 3, alpha 4, alpha 7, beta 2, and beta 4 subunits.

Authors:  K J Elliott; S B Ellis; K J Berckhan; A Urrutia; L E Chavez-Noriega; E C Johnson; G Veliçelebi; M M Harpold
Journal:  J Mol Neurosci       Date:  1996       Impact factor: 3.444

Review 4.  Nicotinic acetylcholine receptors in health and disease.

Authors:  J Lindstrom
Journal:  Mol Neurobiol       Date:  1997-10       Impact factor: 5.590

5.  Nerve growth factor abrogates the tumorigenicity of human small cell lung cancer cell lines.

Authors:  C Missale; A Codignola; S Sigala; A Finardi; M Paez-Pereda; E Sher; P F Spano
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-28       Impact factor: 11.205

6.  Adrenoceptor- and cholinoceptor-mediated mechanisms in the regulation of 5-hydroxytryptamine release from isolated tracheae of newborn rabbits.

Authors:  A Freitag; I Wessler; K Racké
Journal:  Br J Pharmacol       Date:  1996-09       Impact factor: 8.739

7.  Roles of nicotinic acetylcholine receptor beta subunits in function of human alpha4-containing nicotinic receptors.

Authors:  Jie Wu; Qiang Liu; Kewei Yu; Jun Hu; Yen-Ping Kuo; Marsha Segerberg; Paul A St John; Ronald J Lukas
Journal:  J Physiol       Date:  2006-07-06       Impact factor: 5.182

8.  Blockade of nicotinic responses by physostigmine, tacrine and other cholinesterase inhibitors in rat striatum.

Authors:  P B Clarke; M Reuben; H el-Bizri
Journal:  Br J Pharmacol       Date:  1994-03       Impact factor: 8.739

9.  Ciliary neurotrophic factor-induced gene expression in human neuroblastoma cell lines.

Authors:  P Rossino; G Volpe; A Negro; L Callegaro; F Altruda; G Tarone; L Silengo
Journal:  Neurochem Res       Date:  1995-06       Impact factor: 3.996

Review 10.  Guidelines on nicotine dose selection for in vivo research.

Authors:  Shannon G Matta; David J Balfour; Neal L Benowitz; R Thomas Boyd; Jerry J Buccafusco; Anthony R Caggiula; Caroline R Craig; Allan C Collins; M Imad Damaj; Eric C Donny; Phillip S Gardiner; Sharon R Grady; Ulrike Heberlein; Sherry S Leonard; Edward D Levin; Ronald J Lukas; Athina Markou; Michael J Marks; Sarah E McCallum; Neeraja Parameswaran; Kenneth A Perkins; Marina R Picciotto; Maryka Quik; Jed E Rose; Adrian Rothenfluh; William R Schafer; Ian P Stolerman; Rachel F Tyndale; Jeanne M Wehner; Jeffrey M Zirger
Journal:  Psychopharmacology (Berl)       Date:  2006-08-09       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.